NZ200232A - Skin-penetrating pharmaceutical composition in the form of as microemulsion - Google Patents

Skin-penetrating pharmaceutical composition in the form of as microemulsion

Info

Publication number
NZ200232A
NZ200232A NZ200232A NZ20023282A NZ200232A NZ 200232 A NZ200232 A NZ 200232A NZ 200232 A NZ200232 A NZ 200232A NZ 20023282 A NZ20023282 A NZ 20023282A NZ 200232 A NZ200232 A NZ 200232A
Authority
NZ
New Zealand
Prior art keywords
composition
skin
emulsifier
active agent
weight
Prior art date
Application number
NZ200232A
Other languages
English (en)
Inventor
J Franz
J Ziegenmeyer
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ200232A publication Critical patent/NZ200232A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ200232A 1981-04-06 1982-04-05 Skin-penetrating pharmaceutical composition in the form of as microemulsion NZ200232A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (1)

Publication Number Publication Date
NZ200232A true NZ200232A (en) 1985-08-16

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ200232A NZ200232A (en) 1981-04-06 1982-04-05 Skin-penetrating pharmaceutical composition in the form of as microemulsion

Country Status (16)

Country Link
AU (1) AU564570B2 (enrdf_load_stackoverflow)
CA (1) CA1192496A (enrdf_load_stackoverflow)
DE (1) DE3212053A1 (enrdf_load_stackoverflow)
DK (1) DK155882A (enrdf_load_stackoverflow)
ES (1) ES511169A0 (enrdf_load_stackoverflow)
FI (1) FI821123L (enrdf_load_stackoverflow)
FR (1) FR2502951B1 (enrdf_load_stackoverflow)
GB (2) GB2098865B (enrdf_load_stackoverflow)
GR (1) GR75462B (enrdf_load_stackoverflow)
IL (1) IL65424A0 (enrdf_load_stackoverflow)
IT (1) IT8220611A0 (enrdf_load_stackoverflow)
MY (1) MY8600571A (enrdf_load_stackoverflow)
NL (1) NL8201413A (enrdf_load_stackoverflow)
NZ (1) NZ200232A (enrdf_load_stackoverflow)
PT (1) PT74703B (enrdf_load_stackoverflow)
SE (1) SE8202172L (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (enrdf_load_stackoverflow) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
WO1985003878A1 (en) * 1984-03-01 1985-09-12 Sandoz Ag Pharmaceutical compositions
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (en) * 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
EP0684832A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp MICROEMULSIONS CONTAINING PHARMACEUTICAL COMPOSITIONS.
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
EP1331002A3 (en) 1997-01-30 2004-01-14 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin A
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
IN188719B (enrdf_load_stackoverflow) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
BR9916063A (pt) * 1998-12-11 2002-01-22 Pharmasolutions Inc Composições auto-emulsificantes para medicamentos fracamente solúveis em água
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
NZ578735A (en) 2003-12-08 2011-06-30 Cpex Pharmaceuticals Inc Pharmaceutical compositions and methods for insulin treatment
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
JP2021531348A (ja) 2018-07-20 2021-11-18 リポシン，インク． 肝臓病

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (enrdf_load_stackoverflow) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments

Also Published As

Publication number Publication date
IT8220611A0 (it) 1982-04-06
ES8308698A1 (es) 1983-10-01
FI821123A0 (fi) 1982-03-31
ES511169A0 (es) 1983-10-01
GB2098865B (en) 1985-12-18
MY8600571A (en) 1986-12-31
GR75462B (enrdf_load_stackoverflow) 1984-07-20
GB2148711B (en) 1985-12-18
GB2098865A (en) 1982-12-01
NL8201413A (nl) 1982-11-01
FR2502951A1 (fr) 1982-10-08
GB2148711A (en) 1985-06-05
GB8408654D0 (en) 1984-05-16
AU8233482A (en) 1982-10-14
AU564570B2 (en) 1987-08-20
PT74703B (en) 1984-05-30
FR2502951B1 (fr) 1985-12-06
PT74703A (en) 1982-05-01
IL65424A0 (en) 1982-07-30
SE8202172L (sv) 1982-10-07
FI821123A7 (fi) 1982-10-07
FI821123L (fi) 1982-10-07
DK155882A (da) 1982-12-10
CA1192496A (en) 1985-08-27
DE3212053A1 (de) 1982-10-21

Similar Documents

Publication Publication Date Title
NZ200232A (en) Skin-penetrating pharmaceutical composition in the form of as microemulsion
JP6863904B2 (ja) 局所用医薬組成物
US8518376B2 (en) Oil-based foamable carriers and formulations
US9795564B2 (en) Oil-based foamable carriers and formulations
US5314685A (en) Anhydrous formulations for administering lipophilic agents
RU2560677C2 (ru) Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
EP0095813A2 (en) Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
JP2001521547A (ja) 脂質とラノリン誘導界面活性剤を含む水性組成物およびその使用
JP2003040765A (ja) Ｗ／ｏ／ｗ型複合エマルション
KR950003611B1 (ko) 항진균 외용 이미다졸 제제
ZA200210076B (en) Antifungal ketoconazole composition for topical use.
WO1993007874A1 (en) Medicament composition for topical application
JP2623580B2 (ja) 消炎鎮痛クリーム剤
WO1993007901A1 (en) Composition for topical application
JP2844245B2 (ja) 癒合助長用組成物
JP2829157B2 (ja) 皮膚外用剤
HU192749B (en) Process for preparing pharmaceutical compositions for topical administration
FR2572933A1 (fr) Compositions pharmaceutiques topiques a base de tizanidine
JPH09309827A (ja) 抗真菌外用剤
AU2004264680B2 (en) Pharmaceutical compositions of lavendustin
JP2682563B2 (ja) 消炎鎮痛クリーム剤
JPH0517331A (ja) 皮膚外用剤
SK279096B6 (sk) Liečivá masť bez dráždivého účinku na kožu
MXPA96004033A (en) Low ph, hydrolically stable cosmetic compositions containing aci assets
HK1092699B (en) Pharmaceutical compositions of lavendustin